Are drug companies the villain? New study questions claims of ‘evergreening’
For years, brand drug companies have been villainized for “evergreening” or manipulating the law to extend the period of exclusivity for drugs beyond their 20-year
Stuff that matters
For years, brand drug companies have been villainized for “evergreening” or manipulating the law to extend the period of exclusivity for drugs beyond their 20-year
The PROFITH CTS-977 research group from the University of Granada (UGR) has tested the effects of a multi-ingredient dietary nootropic on concentration levels and cognitive
Even after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in advanced liver disease. In cooperation
The dentate gyrus (DG) is a region of the mammalian brain known to support the encoding of new memories. This brain region is part of
Two Medi-Cal care programs designed to help seniors and disabled adults avoid being placed in nursing homes serve only a fraction of those presumed to
For more than a decade, the Care4Rare Canada Consortium (Care4Rare) has provided answers for families living with undiagnosed rare disease. Care4Rare is an international trailblazer
Recent advances in immunotherapy for cancer have stimulated a plethora of studies aimed at developing T cells (white blood cells) and Natural Killer (NK) cells